Hydantoic acid → HCID 86756886, Verbindung

HRID 1979197

Reaktionsgleichung

O1CCCCC1ONC([C@H:11]([C@@H:21]([CH2:37][CH:38]([CH3:40])[CH3:39])[C:22]([NH:24][N:25]([CH2:33][CH:34]([CH3:36])[CH3:35])[C:26](=[O:32])[CH2:27][NH:28][C:29]([NH2:31])=[O:30])=[O:23])[CH2:12]/[CH:13]=[CH:14]/[C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1)=O.[C:41]([OH:48])(=[O:47])CNC(N)=O>>[OH:48][C:41]([C@H:11]([C@@H:21]([CH2:37][CH:38]([CH3:40])[CH3:39])[C:22]([NH:24][N:25]([CH2:33][CH:34]([CH3:36])[CH3:35])[C:26](=[O:32])[CH2:27][NH:28][C:29]([NH2:31])=[O:30])=[O:23])[CH2:12]/[CH:13]=[CH:14]/[C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1)=[O:47]

Komponenten

Edukt 2

HCID 10020Hydantoic acid

HCID 86756885HCID 86756885, Verbindung

Produkt 1

HCID 86756886HCID 86756886, Verbindung

Versuchsvorschrift

The (E)-2(R)-[1(S)-[(tetrahydro-2(RS)-pyranyloxy)carbamoyl]-4-phenyl-3-butenyl]-2′-isobutyl-4-methyl-2′-(2-ureidoacetyl)valerohydrazide used as the starting material was prepared in a manner analogous to Example 11 using hydantoic acid in place of N-acetyl-glycine.

Quellen und Nachweise

ORD-Eintrag: ord-307f79491c1a40a4862459a110b81b37
Quelldatensatz: uspto-grants-2001_05
DOI: 10.6084/m9.figshare.5104873.v1
Patentnummer: US06239151B1

Verknüpfte Notizen

Wird geladen…